FibroBiologics, Inc. Common Stock (FBLG) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2.9M | 6.35M | 5.24M | 10.18M | 9.33M | 14.23M | 8.2M | 6.51M | 8.92M | 9.21M | 10.91M | 11.76M | 0 | 2.63M | 407K |
| Cash & Short-Term Investments | 1.48M | 4.89M | 4.87M | 8.85M | 8.67M | 13.98M | 7.83M | 5.97M | 8.16M | 9.16M | 10.77M | 11.38M | 0 | 2.27M | 407K |
| Cash Only | 1.48M | 4.89M | 4.87M | 8.85M | 8.67M | 13.98M | 7.83M | 5.97M | 8.16M | 9.16M | 10.77M | 11.38M | 0 | 2.27M | 407K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.42M | 1.46M | 373K | 0 | 18K | 18K | 18K | 18K | 18K | 16K | 121K | 314K | 0 | 330K | 0 |
| Total Non-Current Assets | 3.03M | 3.27M | 3.5M | 3.73M | 2.1M | 2.22M | 2.27M | 2.4M | 2.48M | 2.61M | 2.38M | 2.08M | 0 | 2.2M | -407K |
| Property, Plant & Equipment | 2.98M | 3.22M | 3.46M | 3.68M | 2.1M | 2.22M | 2.27M | 2.4M | 2.48M | 2.61M | 2.38M | 2.08M | 0 | 2.2M | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 48K | 48K | 48K | 48K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -407K |
| Total Assets | 5.94M | 9.62M | 8.74M | 13.91M | 11.43M | 16.45M | 10.47M | 8.91M | 11.4M | 11.82M | 13.3M | 13.84M | 0 | 4.82M | 0 |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -48.03% | -41.51% | -16.48% | 56.05% | 0.24% | 39.12% | -21.28% | -35.63% | - | 145.05% | - | - | - | - | - |
| Total Current Liabilities | 1.83M | 1.76M | 6.72M | 10.96M | 8.21M | 12.73M | 6.68M | 10.13M | 13.98M | 9.18M | 1.31M | 942K | 0 | 7.07M | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 1.42M | 2.7M | 1.18M | 1.21M | 814K | 1.44M | 820K | 598K | 0 | 758K | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 723K | 706K | 5.22M | 8.07M | 5.84M | 9.17M | 115K | 287K | 459K | 0 | 0 | 0 | 0 | 5.45M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.11M | 1.05M | 1.51M | 2.27M | 543K | 460K | 4.99M | 8.26M | 12.34M | 7.24M | 0 | 0 | 0 | 538K | 0 |
| Current Ratio | 1.59x | 3.61x | 0.78x | 0.93x | 1.14x | 1.12x | 1.23x | 0.64x | 0.64x | 1.00x | 8.31x | 12.48x | - | 0.37x | - |
| Quick Ratio | 1.59x | 3.61x | 0.78x | 0.93x | 1.14x | 1.12x | 1.23x | 0.64x | 0.64x | 1.00x | 8.31x | 12.48x | - | 0.37x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.51M | 1.7M | 1.9M | 2.08M | 865K | 984K | 1.05M | 1.17M | 1.28M | 1.39M | 1.45M | 1.55M | 0 | 1.75M | 1.29M |
| Long-Term Debt | 1.51M | 1.7M | 1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 2.08M | 865K | 984K | 1.05M | 1.17M | 1.28M | 1.39M | 1.45M | 1.55M | 0 | 1.75M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.29M |
| Total Liabilities | 3.34M | 3.46M | 8.62M | 13.05M | 9.08M | 13.71M | 7.73M | 11.3M | 15.26M | 10.57M | 2.76M | 2.49M | 0 | 8.82M | 1.29M |
| Total Debt | 2.23M | 2.41M | 7.11M | 10.78M | 7.12M | 10.55M | 1.56M | 1.84M | 2.11M | 1.75M | 1.8M | 1.89M | 0 | 7.52M | 0 |
| Net Debt | 750K | -2.48M | 2.25M | 1.93M | -1.55M | -3.43M | -6.26M | -4.14M | -6.05M | -7.42M | -8.97M | -9.48M | 0 | 5.26M | -407K |
| Debt / Equity | 0.86x | 0.39x | 56.90x | 12.53x | 3.03x | 3.86x | 0.57x | - | - | 1.39x | 0.17x | 0.17x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1249.00x | -14.90x | - | - | - | -515.50x | -99.00x | 180.60x | -2114.00x | -9716.00x | - | -215.00x | -16.89x | -5.93x | -8.55x |
| Total Equity | 2.6M | 6.16M | 125K | 860K | 2.35M | 2.73M | 2.74M | -2.39M | -3.86M | 1.25M | 10.54M | 11.35M | 0 | -4M | -1.29M |
| Equity Growth % | 10.64% | 125.08% | -95.43% | 136.03% | 160.83% | 118.28% | -74.03% | -121.03% | - | 131.36% | - | - | 100% | - | - |
| Book Value per Share | 1.16 | 2.76 | 0.06 | 0.45 | 1.28 | 1.57 | 1.63 | -1.46 | -2.48 | 0.79 | 6.49 | 6.99 | - | -2.63 | -0.91 |
| Total Shareholders' Equity | 2.6M | 6.16M | 125K | 860K | 2.35M | 2.73M | 2.74M | -2.39M | -3.86M | 1.25M | 10.54M | 11.35M | 0 | -4M | -1.29M |
| Common Stock | 1K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 1K | 1K | 0 | 1K | 0 |
| Retained Earnings | -59.16M | -54.16M | -50.92M | -45.14M | -40.48M | -35.52M | -32.42M | -31.92M | -32.82M | -24.36M | -14.64M | -12.45M | 0 | -7.87M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.46M | -1.29M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |